InterRent Real Estate Investment Trust

OTCPK:IIPZ.F Stock Report

Market Cap: US$1.2b

InterRent Real Estate Investment Trust Valuation

Is IIPZ.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IIPZ.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IIPZ.F ($7.7) is trading below our estimate of fair value ($9.65)

Significantly Below Fair Value: IIPZ.F is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for IIPZ.F?

Key metric: As IIPZ.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for IIPZ.F. This is calculated by dividing IIPZ.F's market cap by their current revenue.
What is IIPZ.F's PS Ratio?
PS Ratio6.6x
SalesCA$245.57m
Market CapCA$1.62b

Price to Sales Ratio vs Peers

How does IIPZ.F's PS Ratio compare to its peers?

The above table shows the PS ratio for IIPZ.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average5.3x
NXRT NexPoint Residential Trust
4.5x2.3%US$1.2b
CSR Centerspace
4.7x4.1%US$1.2b
ELME Elme Communities
6x4.2%US$1.4b
AIV Apartment Investment and Management
6.1xn/aUS$1.2b
IIPZ.F InterRent Real Estate Investment Trust
6.6x4.9%US$1.6b

Price-To-Sales vs Peers: IIPZ.F is expensive based on its Price-To-Sales Ratio (6.6x) compared to the peer average (5.3x).


Price to Sales Ratio vs Industry

How does IIPZ.F's PS Ratio compare vs other companies in the US Residential REITs Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
CLPR Clipper Realty
0.6x11.4%US$82.96m
No more companies available in this PS range
IIPZ.F 6.6xIndustry Avg. 6.0xNo. of Companies6PS03.67.210.814.418+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: IIPZ.F is expensive based on its Price-To-Sales Ratio (6.6x) compared to the North American Residential REITs industry average (6x).


Price to Sales Ratio vs Fair Ratio

What is IIPZ.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IIPZ.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio6.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate IIPZ.F's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IIPZ.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$7.70
US$9.98
+29.6%
5.0%US$10.76US$9.33n/a11
Nov ’25n/a
US$10.72
0%
5.4%US$11.88US$10.08n/a11
Oct ’25n/a
US$10.89
0%
5.6%US$12.02US$10.01n/a11
Sep ’25US$9.54
US$10.89
+14.2%
5.6%US$12.02US$10.01n/a11
Aug ’25n/a
US$10.95
0%
6.6%US$12.03US$9.84n/a11
Jul ’25US$8.80
US$10.96
+24.5%
6.8%US$12.07US$9.88n/a11
Jun ’25US$8.63
US$10.96
+27.0%
6.8%US$12.07US$9.88n/a11
May ’25n/a
US$11.02
0%
6.5%US$12.04US$10.22n/a10
Apr ’25n/a
US$11.34
0%
5.5%US$12.15US$10.31n/a10
Mar ’25n/a
US$11.13
0%
6.9%US$12.17US$9.59n/a11
Feb ’25US$10.05
US$10.83
+7.8%
9.2%US$11.93US$8.39n/a11
Jan ’25US$9.92
US$10.90
+9.8%
9.7%US$12.34US$8.42n/a11
Dec ’24n/a
US$10.45
0%
12.1%US$12.01US$7.28n/a11
Nov ’24US$8.49
US$10.51
+23.8%
12.3%US$11.90US$7.21n/a11
Oct ’24n/a
US$11.42
0%
11.4%US$12.73US$7.49n/a12
Sep ’24n/a
US$11.42
0%
11.4%US$12.73US$7.49US$9.5412
Aug ’24US$9.89
US$11.62
+17.5%
12.0%US$12.89US$7.39n/a12
Jul ’24n/a
US$11.57
0%
11.7%US$12.71US$7.29US$8.8012
Jun ’24n/a
US$11.57
0%
11.7%US$12.71US$7.29US$8.6312
May ’24n/a
US$11.38
0%
12.6%US$12.46US$6.78n/a12
Apr ’24US$9.73
US$11.22
+15.3%
12.6%US$12.29US$6.69n/a12
Mar ’24US$10.97
US$11.32
+3.2%
12.8%US$12.79US$6.96n/a12
Feb ’24US$10.49
US$11.32
+7.9%
12.8%US$12.79US$6.96US$10.0512
Jan ’24US$9.47
US$11.10
+17.1%
14.0%US$13.45US$6.72US$9.9212
Dec ’23n/a
US$11.10
0%
14.0%US$13.45US$6.72n/a12
Nov ’23US$8.58
US$11.23
+30.9%
16.0%US$13.27US$6.27US$8.4912

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies